Associations of Motor and Neuropsychiatric Symptoms with Comorbidities in Prodromal Parkinson's Disease

Overview

Journal Front Aging Neurosci

Specialty Geriatrics

Date 2024 Dec 10

PMID 39654809

Authors

Jia-Ru Chen

Yan Sun

Yu-Ju Ma

Lan Tan

Affiliations

Soon will be listed here.

Abstract

Objective: To investigate the associations between comorbidities and multimorbidity patterns with motor and neuropsychiatric symptoms in patients with Parkinson's disease (PD) in prodromal PD.

Methods: Multimorbidity is defined as the coexistence of two or more long-term conditions (LTCs) (also known as multiple comorbidities). A total of 921 participants without PD were included in the Parkinson's Progression Markers Initiative (PPMI) database and were categorized according to the LTC count. Participants were evaluated on motor and psychiatric symptoms. Pearson correlation to examine relationship of comorbidities and target symptoms. The baseline population was analyzed using Multiple linear regression model, while mixed effects model was utilized for longitudinal analysis. Fuzzy C-means clustering analysis was conducted to identify comorbidity patterns, followed by multiple linear regression for further analysis.

Results: At baseline, a higher LTC count was significantly correlated with more severe motor (MDS-UPDRS I, II, ADL, all < 0.05) and neuropsychiatric symptoms (QUIP, < 0.001). Three multimorbidity patterns were identified. Among them, the cardiometabolic multimorbidity pattern (CAR) had the most significant correlation with the aforementioned symptoms. Our longitudinal analysis indicated that an increase in the LTC count was associated with the exacerbation of motor and neuropsychiatric symptoms.

Conclusion: Comorbidities were cross-sectionally and longitudinally associated with the motor and neuropsychiatric symptoms of patients with prodromal PD. Among the three multimorbidity patterns, CAR posed the highest threat to the risk of more severe motor and neuropsychiatric symptoms.

References

Weintraub D, Aarsland D, Chaudhuri K, Dobkin R, Leentjens A, Rodriguez-Violante M . The neuropsychiatry of Parkinson's disease: advances and challenges. Lancet Neurol. 2021; 21(1):89-102. PMC: 8800169. DOI: 10.1016/S1474-4422(21)00330-6. View

Grande G, Marengoni A, Vetrano D, Roso-Llorach A, Rizzuto D, Zucchelli A . Multimorbidity burden and dementia risk in older adults: The role of inflammation and genetics. Alzheimers Dement. 2021; 17(5):768-776. PMC: 8247430. DOI: 10.1002/alz.12237. View

Sun Y, Chang Y, Chen H, Su Y, Su H, Li C . Risk of Parkinson disease onset in patients with diabetes: a 9-year population-based cohort study with age and sex stratifications. Diabetes Care. 2012; 35(5):1047-9. PMC: 3329814. DOI: 10.2337/dc11-1511. View

Qiu C, Hu G, Kivipelto M, Laatikainen T, Antikainen R, Fratiglioni L . Association of blood pressure and hypertension with the risk of Parkinson disease: the National FINRISK Study. Hypertension. 2011; 57(6):1094-100. DOI: 10.1161/HYPERTENSIONAHA.111.171249. View

Liang H, Huang Y, Pan S . Parkinson disease and risk of acute myocardial infarction: A population-based, propensity score-matched, longitudinal follow-up study. Am Heart J. 2015; 169(4):508-14. DOI: 10.1016/j.ahj.2014.11.018. View

Goetz C, Tilley B, Shaftman S, Stebbins G, Fahn S, Martinez-Martin P . Movement Disorder Society-sponsored revision of the Unified Parkinson's Disease Rating Scale (MDS-UPDRS): scale presentation and clinimetric testing results. Mov Disord. 2008; 23(15):2129-70. DOI: 10.1002/mds.22340. View

Buchberger B, Huppertz H, Krabbe L, Lux B, Mattivi J, Siafarikas A . Symptoms of depression and anxiety in youth with type 1 diabetes: A systematic review and meta-analysis. Psychoneuroendocrinology. 2016; 70:70-84. DOI: 10.1016/j.psyneuen.2016.04.019. View

Read J, Sharpe L, Modini M, Dear B . Multimorbidity and depression: A systematic review and meta-analysis. J Affect Disord. 2017; 221:36-46. DOI: 10.1016/j.jad.2017.06.009. View

Bahn R . Graves' ophthalmopathy. N Engl J Med. 2010; 362(8):726-38. PMC: 3902010. DOI: 10.1056/NEJMra0905750. View

10.

Kao S, Wang J, Chen S, Li Y, Yang Y, Lo R . Impact of Comorbidity Burden on Cognitive Decline: A Prospective Cohort Study of Older Adults with Dementia. Dement Geriatr Cogn Disord. 2021; 50(1):43-50. DOI: 10.1159/000514651. View

11.

Roberts R, Knopman D, Przybelski S, Mielke M, Kantarci K, Preboske G . Association of type 2 diabetes with brain atrophy and cognitive impairment. Neurology. 2014; 82(13):1132-41. PMC: 3966799. DOI: 10.1212/WNL.0000000000000269. View

12.

Thompson 3rd J, Schaff H, Dearani J, Park S, Sundt 3rd T, Suri R . Risk of recurrent gastrointestinal bleeding after aortic valve replacement in patients with Heyde syndrome. J Thorac Cardiovasc Surg. 2011; 144(1):112-6. DOI: 10.1016/j.jtcvs.2011.05.034. View

13.

Castro-de-Araujo L, Rodrigues E, Machado D, Henriques C, Verotti M, Goncalves A . Multimorbidity worsened anxiety and depression symptoms during the COVID-19 pandemic in Brazil. J Affect Disord. 2022; 314:86-93. PMC: 9259509. DOI: 10.1016/j.jad.2022.07.005. View

14.

. Global, regional, and national incidence, prevalence, and years lived with disability for 310 diseases and injuries, 1990-2015: a systematic analysis for the Global Burden of Disease Study 2015. Lancet. 2016; 388(10053):1545-1602. PMC: 5055577. DOI: 10.1016/S0140-6736(16)31678-6. View

15.

Regnault A, Boroojerdi B, Meunier J, Bani M, Morel T, Cano S . Does the MDS-UPDRS provide the precision to assess progression in early Parkinson's disease? Learnings from the Parkinson's progression marker initiative cohort. J Neurol. 2019; 266(8):1927-1936. PMC: 6647182. DOI: 10.1007/s00415-019-09348-3. View

16.

Potashkin J, Huang X, Becker C, Chen H, Foltynie T, Marras C . Understanding the links between cardiovascular disease and Parkinson's disease. Mov Disord. 2019; 35(1):55-74. PMC: 6981000. DOI: 10.1002/mds.27836. View

17.

Markovic V, Stankovic I, Petrovic I, Stojkovic T, Dragasevic-Miskovic N, Radovanovic S . Dynamics of impulsive-compulsive behaviors in early Parkinson's disease: a prospective study. J Neurol. 2020; 267(4):1127-1136. DOI: 10.1007/s00415-019-09692-4. View

18.

Felez-Nobrega M, Haro J, Koyanagi A . Multimorbidity, depression with anxiety symptoms, and decrements in health in 47 low- and middle-income countries. J Affect Disord. 2022; 317:176-184. DOI: 10.1016/j.jad.2022.08.110. View

19.

Cui J, Qin Y, Tian Y, Ge X, Han H, Yang Z . Activities of daily living as a longitudinal moderator of the effect of autonomic dysfunction on anxiety and depression of Parkinson's patients. Brain Behav. 2021; 11(8):e2297. PMC: 8413789. DOI: 10.1002/brb3.2297. View

20.

Schapira A, Chaudhuri K, Jenner P . Non-motor features of Parkinson disease. Nat Rev Neurosci. 2017; 18(7):435-450. DOI: 10.1038/nrn.2017.62. View